The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference59 articles.
1. Small-cell lung cancer: what we know, what we need to know and the path forward;Gazdar;Nat Rev Cancer,2017
2. Origins, genetic landscape, and emerging therapies of small cell lung cancer;Semenova;Genes Dev,2015
3. Novel strategies for the treatment of small-cell lung carcinoma;William;Nat Rev Clin Oncol,2011
4. Small cell lung cancer: will recent progress lead to improved outcomes;Pietanza;Clin Cancer Res,2015
5. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer;Horn;N Engl J Med,2018
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer;Cell Death & Disease;2024-07-31
2. PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia;Cancers;2023-11-22
3. Corrigendum: The MYC paralog-PARP1 axis as a potential therapeutic target in MYC paralog-activated small cell lung cancer;Frontiers in Oncology;2023-04-12
4. Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors;Acta Pharmacologica Sinica;2022-10-17
5. Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma;OncoImmunology;2022-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3